Open-access publishing finds official favor

UK government backing for open-access publishing while proponents move to promote it more widely

Written byHelen Gavaghan
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Open-access publishing received official support this month when UK funding bodies agreed on a deal with BioMed Central (a partner of The Scientist).

And in an effort to stimulate discussion about the steps needed to promote open access more broadly, an international group of scholars, funders, librarians, editors, and lawyers—both scientists and nonscientists—released a draft definition of open-access publication on the Web on June 20. The definition is part of the "Bethesda statement on open-access publishing," drawn up as a result of a meeting held in April at the headquarters of the Howard Hughes Medical Institute (HHMI) in Chevy Chase, Md.

In a separate development last week, US congressman Rep. Martin Sabo (D-Minn.) introduced a bill in the House of Representatives (June 26) that would prohibit copyright protection for any works stemming from substantially federally funded research.

Under the terms of the deal with BioMed Central, the Joint Information Systems ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery